Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
about
No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study.Influence of age on androgen deprivation therapy-associated Alzheimer's diseasePsychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.The use of exercise interventions to overcome adverse effects of androgen deprivation therapy.Hormone therapy for prostate cancer increases the risk of Alzheimer's disease: a nationwide 4-year longitudinal cohort study.Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer.Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer.Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.Association of Androgen Deprivation Therapy With Alzheimer's Disease: Unmeasured Confounders.Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study.Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer.Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.Reduction of quality of life in prostate cancer patients: experience among 6200 men in the Nordic countries.Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.Reversible Parkinson's Dementia Associated with Withdrawal of Androgen-Deprivation Therapy for Prostate Cancer.Immunogenetics of prostate cancer: a still unexplored field of study.Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate Cancer.Addressing psychosocial concerns for prostate cancer survivors: We've found a problem, now what?Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients.Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer's Disease
P2860
Q33897252-2283099F-7CA8-44AB-B5FF-0F978DED78B3Q36834837-F47EB77E-CCAF-4AAC-9914-328A6D7287F4Q37345771-0BEBDD2D-9E80-47B8-B1F1-3D29D5FF04FEQ38587219-A9406F11-98C6-426A-884A-B6D68B758670Q38817011-5DEDF071-1110-4709-B410-55E4794A4318Q39032138-EF8D718F-9530-428E-BD69-0A8BE70FAE84Q39204570-F2BB6A5C-C5A8-49AB-BE9B-BD67D9BECF9FQ39299593-E5FA2715-EE5E-4F85-8270-F1892197C8B9Q39432668-26617751-98F6-4436-AA47-3A59E0F2D9CAQ39659802-8A261ABA-46AE-4C75-B8D5-7A8ED5053220Q40106293-8556A832-532D-48F1-982A-7C9A05BA113AQ40112597-606988B2-EE76-4C6F-9301-7E6C0EF096CBQ41657822-4E3A3E94-8544-48A0-8E37-85B584F882C4Q42395959-92D36B37-C474-4C47-9BBE-FBAF85E4C396Q47568943-81D6542D-A15F-4018-AA67-57A2281F6222Q47642158-D610F576-473A-40A4-ACA5-85E73C8BDF3DQ47668820-37560113-104B-4FF5-9E14-7B92B0FB59E3Q47701404-90280C66-5008-4B61-9508-46798DE8D418Q47896453-CACB683B-C0BE-4622-BBF1-D5D217797D7FQ48293436-467AB1FB-E3C0-4D3A-874A-5EC7BEB6D615Q50082109-7C6E9451-44DF-4323-A8DA-18BBB788D992Q50532106-99E368ED-5B27-4879-B6B5-B48F852C9067Q53888703-A91FE054-6292-442A-87F3-A0F719A139A5Q55422473-7DAF07E8-12EA-4F9F-8602-E701E2839446Q58797229-B4D6C9F7-65CF-4DC6-B068-FBA68124D9FD
P2860
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Course and Predictors of Cogni ...... rapy: A Controlled Comparison.
@ast
Course and Predictors of Cogni ...... rapy: A Controlled Comparison.
@en
type
label
Course and Predictors of Cogni ...... rapy: A Controlled Comparison.
@ast
Course and Predictors of Cogni ...... rapy: A Controlled Comparison.
@en
prefLabel
Course and Predictors of Cogni ...... rapy: A Controlled Comparison.
@ast
Course and Predictors of Cogni ...... rapy: A Controlled Comparison.
@en
P2093
P2860
P50
P356
P1476
Course and Predictors of Cogni ...... erapy: A Controlled Comparison
@en
P2093
Brent J Small
Heather S L Jim
Jong Y Park
Margaret Booth-Jones
Mayer N Fishman
Philippe E Spiess
Steven K Sutton
P2860
P304
P356
10.1200/JCO.2014.60.1963
P407
P577
2015-05-11T00:00:00Z